Skip to Main Content

Author Details

Michael Dworzak
St. Anna Children's Cancer Research Institute (CCRI)
1990
209
51
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37345487Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard-risk acute myeloid leukemia.Haematologica2024
37743097Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias.Br J Haematol2024
37584291Spontaneous remission and loss of monosomy 7: a window of opportunity for young children with SAMD9L syndrome.Haematologica2024
37945316Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup.Br J Haematol2024
37776305FCM marker importance for MRD assessment in T-cell acute lymphoblastic leukemia: An AIEOP-BFM-ALL-FLOW study group report.Cytometry A2024
36370190Prevalence of anemia at diagnosis of pediatric chronic myeloid leukemia and prognostic impact on the disease course.Ann Hematol2023
37695474Azacitidine (Vidaza<sup>®</sup>) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015).Paediatr Drugs2023
37535134Prospective use of molecular minimal residual disease for risk stratification in children and adolescents with acute lymphoblastic leukemia : Long-term results of the AIEOP-BFM ALL 2000 trial in Austria.Wien Klin Wochenschr2023
35848787Incidence and Risk Factors of Venous Thromboembolism in Childhood Acute Lymphoblastic Leukaemia - a Population-Based Analysis of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group.Pediatr Hematol Oncol2023
37019990The KMT2A recombinome of acute leukemias in 2023.Leukemia2023
37141547Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Acute Lymphoblastic Leukemia Intercontinental-Berlin-Frankfurt-Münster 2009 Trial.J Clin Oncol2023
36996387Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood <i>KMT2A</i>-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group.J Clin Oncol2023
36815378Comprehensive molecular and clinical characterization of <i>NUP98</i> fusions in pediatric acute myeloid leukemia.Haematologica2023
36707619Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations.Leukemia2023
36823455Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft.Bone Marrow Transplant2023
34532968Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study.Pediatr Blood Cancer2022
35646299Relapsed acute lymphoblastic leukaemia after allogeneic stem cell transplantation: a therapeutic dilemma challenging the armamentarium of immunotherapies currently available (case reports).Ther Adv Hematol2022
35580337An R307H substitution in GATA1 that prevents Ser310 phosphorylation causes severe fetal anemia.Blood Adv2022
35812385Case Report: Refractory Cytopenia With a Switch From a Transient Monosomy 7 to a Disease-Ameliorating del(20q) in a <i>NHEJ1</i>-Deficient Long-term Survivor.Front Immunol2022
36051012Second malignant neoplasms after treatment of 1487 children and adolescents with acute lymphoblastic leukemia-A population-based analysis of the Austrian ALL-BFM Study Group.EJHaem2022
34854279Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS.Haematologica2022
35205645UMAP Based Anomaly Detection for Minimal Residual Disease Quantification within Acute Myeloid Leukemia.Cancers (Basel)2022
33034135Features and outcome of chronic myeloid leukemia at very young age: Data from the International Pediatric Chronic Myeloid Leukemia Registry.Pediatr Blood Cancer2021
33784434Presence of viremia during febrile neutropenic episodes in patients undergoing chemotherapy for malignant neoplasms.Am J Hematol2021
33672815Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group.Cancers (Basel)2021
33755341Characteristics, management, and outcome of pediatric patients with post-transplant lymphoproliferative disease-A 20â¿¿years' experience from Austria.Cancer Rep (Hoboken)2021
34885257An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report.Cancers (Basel)2021
34469508Association of unbalanced translocation der(1;7) with germline GATA2 mutations.Blood2021
34407551Recommendations for Diagnosis and Treatment of Children with Transient Abnormal Myelopoiesis (TAM) and Myeloid Leukemia in Down Syndrome (ML-DS).Klin Padiatr2021
34657125Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants.Blood Cancer J2021
34301409The variable biological signature of refractory cytopenia of childhood (RCC), a retrospective EWOG-MDS study.Leuk Res2021
34244664Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome.Bone Marrow Transplant2021
34066095Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG.Cancers (Basel)2021
34050156Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden.Nat Commun2021
34108513Diagnosis and management of acute appendicitis in 21 pediatric hematology and oncology patients at a tertiary care cancer center.Sci Rep2021
32155835Age-Dependent Presentation and Clinical Course of 1465 Patients Aged 0 to Less than 18 Years with Ovarian or Testicular Germ Cell Tumors; Data of the MAKEI 96 Protocol Revisited in the Light of Prenatal Germ Cell Biology.Cancers (Basel)2020
32037692Management of children and adolescents with gray zone lymphoma: A case series.Pediatr Blood Cancer2020
32823516Expression Patterns of Coagulation Factor XIII Subunit A on Leukemic Lymphoblasts Correlate with Clinical Outcome and Genetic Subtypes in Childhood B-cell Progenitor Acute Lymphoblastic Leukemia.Cancers (Basel)2020
32853382The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL.Blood Adv2020
32555368Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency.Leukemia2020
30561169Flow-cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B-cell precursor acute lymphoblastic leukemia in trial AIEOP-BFM-ALL 2000.Pediatr Blood Cancer2019
32072137Phospho-Profiling Linking Biology and Clinics in Pediatric Acute Myeloid Leukemia.Hemasphere2019
31681710Flow-Cytometric Monitoring of Minimal Residual Disease in Pediatric Patients With Acute Myeloid Leukemia: Recent Advances and Future Strategies.Front Pediatr2019
30093401Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia: a report by Berlin-Frankfurt-Münster study group.Haematologica2019
31282025Automated Flow Cytometric MRD Assessment in Childhood Acute B- Lymphoblastic Leukemia Using Supervised Machine Learning.Cytometry A2019
31276318Phase I dose-escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors.Pediatr Blood Cancer2019
30705095CD371 cell surface expression: a unique feature of <i>DUX4</i>-rearranged acute lymphoblastic leukemia.Haematologica2019
30825249Rothia mucilaginosa bacteremia: A 10-year experience of a pediatric tertiary care cancer center.Pediatr Blood Cancer2019
28701730The MLL recombinome of acute leukemias in 2017.Leukemia2018
30150206Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group.Blood2018
  • 1 - 50 of 209

Recommended Authors

Adam J Lamble
Seattle Children's Hospital, University of Washington
Career Start Year 2017
Number of shared co-authors 9
Anna Raimbault
CHU La Miletrie University Hospital Poitiers France.
Career Start Year 2012
Number of shared co-authors 6
Amanda Winters
University of Colorado School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Thomas K??hnke
Cancer Institute, Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Friedrich St??lzel
University Hospital TU Dresden
Career Start Year 2008
Number of shared co-authors 5
Kara L Davis
Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 4
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 0
Marlise R Luskin
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 2
Thomas Cluzeau
Universite Nice Cote d'azur, CHU de Nice
Career Start Year 2005
Number of shared co-authors 2
Jean-Baptiste Micol
INSERM U7, Universite Paris-Saclay
Career Start Year 2004
Number of shared co-authors 3
Patrick Brown
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Career Start Year 2004
Number of shared co-authors 6
Christopher S Hourigan
and Blood Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 2
Christoph R??llig
Hopp Children's Cancer Center (KiTZ)
Career Start Year 2000
Number of shared co-authors 6
Emmanuel Raffoux
Universite Paris Diderot
Career Start Year 1998
Number of shared co-authors 5
Farhad Ravandi
University of Texas M.D. Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 6
Bruno C Medeiros
AbbVie Inc.
Career Start Year 1996
Number of shared co-authors 6
Thoralf Lange
Hospital Weissenfels
Career Start Year 1994
Number of shared co-authors 1
Jean Soulier
University of Paris
Career Start Year 1993
Number of shared co-authors 12
Meenakshi Devidas
St Jude Children's Research Hospital
Career Start Year 1993
Number of shared co-authors 9
Stephen P Hunger
Children's Hospital of Philadelphia
Career Start Year 1990
Number of shared co-authors 11
Claude Preudhomme
Lille University Hospital, INSERM UMR-S7, CNRS UMR9020, Lille University.
Career Start Year 1989
Number of shared co-authors 7
Daniel J DeAngelo
Dana-Farber Cancer Institute
Career Start Year 1989
Number of shared co-authors 4
Sima Jeha
St. Jude Children's Research Hospital
Career Start Year 1988
Number of shared co-authors 3
Alan S Wayne
Cancer and Blood Disease Institute, Children's Hospital Los Angeles
Career Start Year 1986
Number of shared co-authors 1
Richard M Stone
Dana Farber Cancer Institute
Career Start Year 1986
Number of shared co-authors 11
Torsten Haferlach
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 1983
Number of shared co-authors 18
Martin S Tallman
Memorial Sloan-Kettering Cancer Center
Career Start Year 1982
Number of shared co-authors 15
Dietger Niederwieser
University of Leipzig
Career Start Year 1982
Number of shared co-authors 8
Stefan Burdach
Technische Universitat Munchen
Career Start Year 1981
Number of shared co-authors 21
Ching-Hon Pui
St. Jude Children's Research Hospital
Career Start Year 1980
Number of shared co-authors 8

Collaborators

Charlotte M Niemeyer
Co-authored papers 22
Dieter Printz
Children's Cancer Research Institute
Co-authored papers 15
Gerhard Fritsch
AUVA Trauma Hospital Salzburg
Co-authored papers 12
Thomas Klingebiel
Co-authored papers 11
Gudrun G??hring
Hannover Medical School
Co-authored papers 10
Heidrun Boztug
St. Anna Children's Hospital, Medical University of Vienna
Co-authored papers 10
Gudrun Fleischhack
Co-authored papers 8
Todd A Alonzo
Keck School of Medicine, University of Southern California
Co-authored papers 7
Norbert Graf
Clinical Trials Unit
Co-authored papers 7
Peter F Ambros
Children's Cancer Research Institute, Medical University of Vienna
Co-authored papers 6
Soheil Meshinchi
Fred Hutchinson Cancer Research Centre
Co-authored papers 5
Karin Dieckmann
Medical University of Vienna
Co-authored papers 5
Edward A Kolb
Co-authored papers 5
Caroline Hutter
Children's Cancer Research Institute, Medical University of Vienna
Co-authored papers 5
Gernot Engstler
St Anna Children's Hospital, Medical University of Vienna
Co-authored papers 5
Cornelia Eckert
Co-authored papers 4
Markus G Seidel
Medical University of Graz
Co-authored papers 4
Claudia Rossig
University Children's Hospital Muenster
Co-authored papers 4
Beat W Sch??fer
Department of Oncology and Children's Research Center, University Children's Hospital
Co-authored papers 4
Maximilian Kauer
St. Anna Children's Cancer Research Institute (CCRI)
Co-authored papers 3
Richard Aplenc
Children's Hospital of Philadelphia
Co-authored papers 3
Emmanuelle Clappier
Saint-Louis Hospital
Co-authored papers 3
Lillian Sung
The Hospital for Sick Children
Co-authored papers 2
Rhonda E Ries
Clinical Research Division, Fred Hutchinson Cancer Research Center
Co-authored papers 2
Christoph Bock
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 2
Wolfgang Holter
St. Anna Children's Hospital, Medical University of Vienna
Co-authored papers 2
Arndt Borkhardt
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Co-authored papers 2
Inge M Ambros
St. Anna Children's Cancer Research Institute
Co-authored papers 2
Markus Metzler
University Hospital Erlangen
Co-authored papers 2
Manuela Krumbholz
University Hospital Erlangen
Co-authored papers 2
Release 1.2